EXPLORE!

New IRDA circular

  2133 Views

Dr KK Aggarwal    31 July 2018

Morning MEDtalks with Dr KK Aggarwal 31st July 2018

NABH entry level accreditation extended for one year

Circular No. IRDA/HLT/REG/CIR/146/07/2016 DT.29.7.2016: the due date to get the entry level NABH certification was July, 2018 and the same has been extended for one more year.

INSURANCE REGULATORY AND DEVELOPMENT AUTHORITY OF INDIA

Ref: IRDAI/HLT/GDL/C IR/114/07/2018/ 27th July, 2018

To All Insurance Companies and Third Party Administrators

Re: Modified Guidelines on Standards and Benchmarks for hospitals in the provider network

On examining the extent of compliance to the standards and benchmarks specified, in supercession of Clause (a) and Clause (b) of Chapter IV of Guidelines on Standardization in Health Insurance issued vide Circular Ref: IRDA/HLT/REG/CIR/146/07/2016 dated 29th July, 2016, the following modified Clause (a) and Clause (b) are issued.

  1. All the existing Network Providers shall, within twelve months from the date of notification of these modified guidelines, comply with the following:
  1. Register with Registry of Hospitals in the Network of Insurers (ROHINI) maintained by Insurance Information Bureau (IIB). [https://rohini.iib.gov.in/].
  2. Obtain either Pre-entry level Certificate (or higher level of certificate) issued by National Accreditation Board for Hospitals and Healthcare Providers (NABH) or State Level Certificate (or higher level of certificate) under National Quality Assurance Standards (NQAS), issued by National Health Systems Resources Centre (NHSRC).

For the new entrants from the date of notification of these modified Guidelines, only those hospitals that are compliant with the requirements specified at Clause (a) (i) above shall be enlisted as network providers.

These network providers shall comply with the requirements stipulated at Clause (a) (ii) above within one year from the date of enlisting as a Network Provider and this shall be one of the conditions of Health Services Agreement.

b.  Insurers and TPAs may also endeavour to get hospitals (other than Network Providers) involved in reimbursement claims to meet the requirements stipulated at Clause (a) (i) and (a) (ii) above.

This is issued in terms of Regulation (31) (e) of IRDAI (Health Insurance) Regulations, 2016.

These modified guidelines are applicable with immediate effect.

General Manager (Health)

Approach to a patient on aspirin going for non-cardiac surgery

  1. Is the patient on aspirin for primary prophylaxis? Discontinue aspirin for five to seven days before the surgery and start as soon as the perioperative risk of major bleeding has passed.
  2. Is the patient on long term aspirin for secondary prophylaxis? Continue aspirin in patients with prior PCI with stenting and those undergoing carotid endarterectomy, unless the risk of major bleeding is thought to be high (POISE-2 trial) or the surgery involved is not likely to have bleeding controlled by homeostasis (prostate surgery, intra ocular surgery, intra cranial surgery)
  3. Aspirin can be safely continued in most patients undergoing minor dental surgery or dermatologic procedures.
  4. Guidelines from the American Society of Regional Anesthesia (ASRA) indicate that NSAIDs, including aspirin do not create a level of risk that will interfere with the performance of neuraxial blocks, and should not impact catheter techniques, timing of neuraxial catheter removal, or postoperative monitoring.
  5. Cilostazol should be discontinued for at least two to three days prior to elective surgery.
  6. There is no data on the safety of dipyridamole if continued in the perioperative period. If discontinued, the drug should be stopped at least two days before surgery.

 

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with stenting

  1. Defer non-emergent noncardiac surgery for at least six months irrespective of stent type.
  2. In patients who must undergo non-emergent (time sensitive) noncardiac surgery prior to six months attempt to defer surgery for at least three months after bare metal or drug-eluting stent placement. In patients for whom surgery before three months is in their best interest after weighing risks and benefits refer patients as early as one month after stent placement.
  3. For most patients undergoing noncardiac surgery who are taking DAPT after PCI with stenting because they have not reached the recommended minimum duration of such therapy continue DAPT, as opposed to stopping it prior to surgery
  4. In patients for whom the risk of bleeding is likely to exceed the risk of a perioperative event due to the premature cessation of DAPT continue aspirin alone.
  5. In patients for whom a bleeding complication could be catastrophic, such as patients undergoing neurosurgical, prostate, or posterior eye procedures, stop both antiplatelet agents
  6. For patients taking DAPT after PCI with balloon angioplasty who are scheduled to undergo elective noncardiac surgery wait at least 14 days after PCI
  7. Clopidogrel, prasugrel, and ticagrelor when stopped should be stopped five, seven, and three to five days, respectively, before surgery.
  8. Clopidogrel, if stopped, should be restarted with a loading dose of 300 – 600 mg as soon as possible after surgery, perhaps even later in the day if postoperative bleeding has stopped.
  9. Surgery be performed in centers with 24-hour interventional cardiology coverage

A new oral drug for endometriosis pain

USFDA has announce the approval of the commercial version of the drug elagolix for the treatment of endometriosis pain. This is the first time in over a decade that an oral treatment specifically designed for endometriosis pain has been approved. Elagolix is the first and only oral gonadotropin-releasing hormone antagonist designed specifically for endometriosis.

 

Unregulated food additives could harm children

The University of Washington backed by the American Academy of Pediatrics (AAP) is now calling on the FDA to review more than 1,000 food additives generally recognized as safe. The US allows more than 10,000 additives to be used in modifying taste or the appearance of food, many of which were grandfathered in during the 1950s. Some additives to watch out for

 

  1. Artificial food colors:Are common in children’s food products. Now, they may be associated with worsened attention-deficit/hyperactivity disorder symptoms. Studies in the report found that kids who cut out synthetic food colorings from their diets had decreased ADHD symptoms.
  2. Bisphenols (BPA): are used to harden plastic containers and line metal cans. They can act like estrogen in the body and may alter the timing of puberty, slow fertility, increase body fat, and negatively impact the nervous and immune systems. Currently, BPA is banned in baby bottles and sippy cups.
  3. Phthalates:are found in plastic and vinyl tubes to make them flexible, and may now affect male genital development, increase childhood obesity, and contribute to cardiovascular disease. In 2017, the use of some phthalates in childcare products, like teething rings, were banned.
  4. Perfluoroalkyl chemicals (PFCs):  are used in grease-proof paper and cardboard food packaging, and now may reduce immunity, birth weight and fertility. They may also affect the thyroid system, metabolism, digestion, muscle control, brain development and bone strength.
  5. Perchlorate: are added to some dry food packaging to help control static electricity. Now, it’s known to disrupt thyroid function, early life brain development and growth.
  6. Nitrates / nitrites:Are used to preserve food and enhance color, specifically in cured and processed meats. These additives can interfere with thyroid hormone production and hinder blood from moving oxygen in the body. It has also been linked with gastrointestinal and nervous system cancers. (Source Komonews, Dr. Sheela Sathyanarayana, a UW Medicine pediatrician and co-author of the study)

 

A Portfolio diet lowers many risk factors for heart disease

A Portfolio diet, a plant-based way of eating reduces not only LDL cholesterol, but also other risk factors for heart disease such as blood pressure, triglycerides and inflammation thereby reducing the overall risk for coronary heart disease by 13% as per a meta-analysis of seven trials reported in Progress in Cardiovascular Diseases.

The portfolio diet has four main components. Based on a 2,000 calorie diet, it includes 45 grams of nuts, or about a handful; 50 grams of plant protein such as soy, or pulses like beans and peas; 20 grams of viscous soluble fiber (oats, eggplant, apples, etc.) and plant sterols 2 gm (natural compounds that inhibit absorption of cholesterol and are often included in enriched products like margarine).

David JA Jenkins, MD, creator of the portfolio diet says, “Dont think of the portfolio diet as a diet; think of it as an investment in lower cholesterol”.

Around the globe

  1. The US arm of Sun Pharmaceutical is recalling over 2,500 bottles of Metformin hydrochloride extended release tablets from Arizona on account of presence of foreign substance in one lot. The reason for recall is presence of foreign substance- one lot of these tablets contains foreign matter identified as a piece of rubber glove detected in one tablet.
  2. A CDC final investigation update of a multistate outbreak of Salmonella infections linked to pre-cut melon recommends that consumers, restaurants and retailers choose and handle fruit safely to help prevent foodborne illnesses, hands and food preparation surfaces should be washed before and after preparing fruit and pre-cut fruits should be refrigerated at 40ºF or colder. As of July 26, 2018, this outbreak appears to be over.
  3. ICMR-National Institute of Epidemiology free online course on ‘Health Research Fundamentals’ begins from 6th August 2018. The first in the NIeCer series, Health Research Fundamentals (NIeCer 101) is a basic level course in health research methods. The total duration of the course is 20 hours to be completed in 8 weeks. The participants will learn through video lectures, presentation slides, quizzes and readings. The participants desirous of obtaining certificate have to appear for final certification exam at the end of the course for which Rs. 1100/- is to be paid as examination fee. The certification exam will be conducted at the end of the course at designated centres in selected cities of India.
  4. Over 30 parliamentarians from countries in WHO South-East Asia Region have adopted a ‘Call to Action’ at the end of the two-day ‘South-Asia Regional Parliamentarians’ Meeting – A renewed commitment to women’s, children’s and adolescents’ health’ as a mark of their commitment to health and wellbeing of women, children and adolescents, to further reduce preventable diseases and deaths among them.

Video to watch: https://www.facebook.com/drkkaggarwal/videos/1934225719932055/

Participate in survey on inflammatory bowel disease:

https://docs.google.com/forms/d/e/1FAIpQLSedaDx2iXiwU1vBpYdU6ebfCap-7PYAPSqXRJTeg8ULvNOcLg/viewform

 

Dr KK Aggarwal

Padma Shri Awardee

President HCFI

Vice President CMAAO

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.